welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Kathryn R. Wagner, MD, PhD

Center for Genetic Muscle Disorders
Kennedy Krieger Institute
801 N. Broadway
Baltimore, Maryland, United States

Kathryn R. Wagner, MD, PhD is the director of the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute and a professor of neurology and neuroscience at the Johns Hopkins School of Medicine. She treats patients with muscular dystrophies in a multidisciplinary clinic, addressing the multiple medical and social issues affecting these individuals and their families.

Dr. Wagner obtained her undergraduate degree from Yale University, graduating summa cum laude with honors in biology. She participated in the NIH-funded medical scientist training program and obtained her medical and doctoral degrees at Johns Hopkins. She completed her internship in internal medicine and residency in neurology at Johns Hopkins. She also completed her neuromuscular fellowship at Johns Hopkins.

Dr. Wagner focuses her laboratory and clinical research on developing methods to promote muscle regeneration. A major emphasis has been on modulating myostatin, a potent regulator of muscle growth. She conducts clinical trials in muscular dystrophy, including the first clinical trial of nonsense suppression in Duchenne and the first clinical trial of myostatin inhibition in adult muscular dystrophy.


Repersentative Publications:

Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model

Contemporary cardiac issues in Duchenne muscular dystrophy

Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy

‘Double trouble’: Diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia

Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy